A Framework for Developing Pharmacotherapy for Agitation in Alzheimer’s disease: Recommendations of the ISCTM Working Group - 21/11/24
Doi : 10.14283/jpad.2020.37
Cedric O’Gorman 1, 12, ⁎, ⁎ 
, R. Khoury 2, A. Anderson 3, M. Carter 4, F. DiCesare 5, S. Dubé 6, L. Ereshefsky 7, G. Grossberg 2, N. Hefting 8, S. Khan 4, S. Lind 8, H. Moebius 9, T. Shiovitz 10, P. Rosenberg 11
, R. Khoury 2, A. Anderson 3, M. Carter 4, F. DiCesare 5, S. Dubé 6, L. Ereshefsky 7, G. Grossberg 2, N. Hefting 8, S. Khan 4, S. Lind 8, H. Moebius 9, T. Shiovitz 10, P. Rosenberg 11ISCTM: International Society for CNS Clinical Trials and Methodology
1 Axsome Therapeutics Inc., New York, NY, USA
2 Department of Psychiatry and Behavioral Neuroscience, Saint Louis University School of Medicine, Saint Louis, MO, USA
3 Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA
4 Pfizer Inc., Collegeville, PA, USA
5 Leoben Research srl, Rome, Italy
6 Avanir Pharmaceuticals Inc., Aliso Viejo, CA, USA
7 Follow the Molecule LLC and Alliance for Early Phase, Marina del Rey, Los Angeles, CA, USA
8 H. Lundbeck A/S, Valby, Denmark
9 moebius-consult GmbH, Baar, Zürich, Switzerland
10 California Neuroscience Research Medical Group Inc., CTSdatabase LLC., Sherman Oaks, CA, USA
11 Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
12 200 Broadway (3rd Floor), 10038, New York, NY, USA
a cogorman@axsome.com
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Mappa
| Dedication: This article is dedicated to the memory of Dr. Brendon Binneman who contributed generously of his time and expertise in the early stages of this project. |
© 2020
THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Vol 7 - N° 4
P. 274-282 - settembre 2020 Ritorno al numero
Articolo precedente
- The Interrelationship between Insulin-Like Growth Factor 1, Apolipoprotein E ε4, Lifestyle Factors, and the Aging Body and Brain
- Sara A. Galle, I.K. Geraedts, J.B. Deijen, M.V. Milders, M.L. Drent
- Self-Administered Cognitive Testing by Older Adults At-Risk for Cognitive Decline
- Elena Tsoy, K.L. Possin, N. Thompson, K. Patel, S.K. Garrigues, I. Maravilla, S.J. Erlhoff, C.S. Ritchie
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.